The myristoylation of the foot-and-mouth disease virus (FMDV) capsid precursor P1-2A and its aminoterminal cleavage product lAB, expressed from subgenomic cDNA, has been analysed. The modification reaction is independent of other FMDV proteins and occurs in both mammalian and insect cells. Blocking of the myristoylation site does not prevent efficient processing of the FMDV capsid precursor. A cDNA cassette in which the leader protease sequence is substituted by an ATG codon produces myristoylated lAB, indicating correct removal of the novel Nterminal methionine residue.
The capsid of picornaviruses consists of 60 copies of four different proteins: 1A (VP4), 1B (VP2), 1C (VP3) and 1D (VP1). It has been shown, in representatives from each genus of the Picornaviridae, that the amino terminus of 1A is modified by the addition of a myristate moiety to the terminal glycine residue (Chow et al., 1987; Paul et al., 1987) . This modification must follow either the removal of the terminal methionine residue in the enteroviruses (e.g. poliovirus) or the removal of the leader (L) protein in the aphthoviruses [foot-and-mouth disease virus (FMDV)] and cardioviruses. The precursor proteins of 1A, namely lAB (VP0) and P1, have also been shown to contain myristate (Chow et aL, 1987) suggesting that the modification is an early event. The amino termini of picornavirus 1A proteins contain a consensus sequence (G-X-X-S/T) for myristoylation found in other viral and cell proteins (see review by Towler et al., 1988) .
Mutagenesis of the myristoylation consensus sequence in poliovirus cDNA is lethal (Marc et al., 1989; Krausslich et al., 1990) suggesting that this modification is essential for the life-cycle of the virus. The role of the myristate group is however not yet established. It has been suggested that the processing and assembly of the capid precusors may be dependent on the myristate addition (Chow et al., 1987; Marc et al., 1989 Marc et al., , 1990 Krausslich et al., 1990 ). An alternative role could be that this modification directs the capsid precursors to the membranes where RNA replication is occurring (Paul et al., 1987) . The earlier studies on the myristoylation of picornavirus proteins used the intact virus or the in vitro translation products of full-length virus RNA (or RNA transcripts), thus any involvement of non-structural virus proteins in the modification of the capsid precursor has not been determined.
In previous studies we have determined the properties of self-processing FMDV precursors expressed from cDNA in both mammalian ) and insect cells (Roosien et al., 1990) . Production and correct cleavage of the FMDV P1-2A capsid precursor protein to lAB, 1C and 1D (note these are the fully processed products obtained in the absence of encapsidation) can be achieved by the expression of the MR1 cassette ( Fig.  la) which encodes L, P1-2A and 3C. The L protein cleaves itself from the amino terminus of P1-2A and the 3C protease is responsible for the 1AB/1C, 1C/1D and 1D/2A cleavages. Omission or inactivation of the L (as in CA103 and CAK cassettes) or 3C (as in the MR3 cassette) proteases produces the expected loss of processing activity (see Fig. 2 and Roosien et al., 1990) .
The CAK cassette has the L protease precisely removed by site-directed mutagenesis and an initiation codon placed immediately adjacent to the sequence encoding the amino terminus of the P1-2A precursor (Fig. 1 b) . This was achieved using the polymerase chain reaction (PCR) [20 cycles of 45 °C (0.55 min), 70 °C (2 min) and 95°C (0.55 min)] with Taq polymerase (CamBio Type III) and the oligonucleotide 5' CACT-GAAAACATGGGGGCTGGAC 3', and the reverse Roosien et al., 1990) . (b) Precise deletion of the L protein coding sequence and introduction of an initiation codon at the amino terminus of the P1-2A precursor as described in the text. The nucleotide and amino acid (single letter code) sequences are shown. Note the myristoylated glycine residue becomes the second residue in the novel PI-2A precursor and hence the terminal methionine residue must be removed for this modification to occur. HindlII/KpnI-digested pMR1 to produce pCAK. All cassettes used in mammalian cells in this study were inserted into plasmids under the control of the bacteriophage T7 promoter and assayed in the transient expression system developed by Fuerst et al. (1986) as described in . Briefly, plasmid DNA (5 ~tg) was transfected, using lipofectin (BRL), into BSC40 cells (35 mm dish) which were infected with the vaccinia virus recombinant vTF7-3 which expresses the T7 RNA polymerase. After 20 h, cells were incubated with [35S]methionine (50 ~tCi) or [3H]myristate (50 ~tCi) for 2 h and cell extracts were prepared. FMDV proteins were immunoprecipitated using anti-FMDV hyperimmune guinea-pig serum and analysed by SDS-PAGE (Laemmli, 1970) . Gels were impregnated with PPO (Bonner & Laskey, 1974) prior to exposure to X-ray film.
The MR3 cassette produces the intact P 1-2A precursor in cells and this product was observed using both [35S]methionine and [3H]myristate (Fig. 2 , lanes 5 and 10) (note that this product migrates similarly to a asslabelled vaccinia virus protein which is non-specifically immunoprecipitated but the intensity is clearly greatest in lane 5). When the 3C protease was included in the cassette (as in the MR1 cassette) the PI-2A product was completely processed to produce lAB, IC and 1D as observed with methionine labelling but only the lAB product contained myristate as expected (lanes 2 and 7) . The interruption of the L coding sequence (as in the CA103 cassette) prevented the cleavage of the truncated AL protein from the amino terminus of P 1-2A. However this did not block the ability of 3C to process the precursor, so AL1AB, 1C and 1D were produced (Fig. 2 , lane 3) (note multiple forms of AL1AB are observed due to the two points of translational initiation in FMDV and a trace of the ALP1-2A product is visible in lane 3 migrating more slowly than the P1-2A product). No myristate was incorporated into the AL1AB products (lane 8); however, a low level of incorporation into proteins migrating close to authentic lAB was observed in some experiments. The origin of these products is uncertain. We have noted previously ) that a product termed lAB' is generated from the CA 103 cassette probably by a low level of cleavage by 3C at a site within L; further proteolysis (by cell or viral proteins) of this product could generate authentic lAB. The products observed from the CAK cassette, which lacks the L sequence, are identical to those found with the MR1 cassette both by methionine and myristate labelling ( Fig. 2, lanes 4 and 9; lanes 2 and 7) . Taken together these observations show that only the P1-2A precursor is required for the myristoylation of the amino terminus to occur, since the only non-structural proteins, L and 3C, in the cassettes can both be deleted without inhibiting the reaction. The product of the CAK cassette contains a methionine residue at the amino terminus of P1-2A; as methionine is not a substrate for myristoylation it follows that the cell is capable of removing this 'foreign' methionine residue.
Since in mammalian cells the myristoylation of the P 1-2A precursor was independent of other FMDV proteins we were interested to know whether this process would also occur in non-mammalian cells. We have examined the myristoylation of the FMDV capsid precursor within insect [Spodoptera frugiperda (Sf) ] cells infected with Autographa californica nuclear polyhedrosis virus (AcNPV) vectors. The recombinant Ac611MRI con- Cell extracts were prepared, immunoprecipitated with guinea-pig anti-FMDV hyperimmune serum and analysed by SDS-PAGE and fluorography. The methionine-labelled products were exposed to film for 2 days and the myristate-labelled products were exposed to film for 6 weeks. Cassettes expressed were: lanes 1 and 6, no DNA (control); lanes 2 and 7, MR1 ; lanes 3 and 8, CA 103; lanes 4 and 9, CAK; lanes 5 and 10, MR3.
taining the MR1 cassette has been described previously (Roosien et al., 1990) and was used to infect Sf21 cells. After 48 h, cells were incubated with [3H]myristate or [35S]methionine and processed as above. The pattern of FMDV products observed from the Ac611 MR 1-infected cells using methionine labelling (not shown) is identical to that observed in mammalian cells from the MR1 cassette (Fig. 2, lane 2) and has been reported previously (Roosien et al., 1990) . Using the myristate label both the P1-2A precursor and the processed product lAB are observed in the immunoprecipitated material from the Ac611MRl-infected cells (Fig. 3, lane 2) . No myristoylated products were precipitated from the uninfected or wild-type AcNPV-infected cells (lanes 1 and 3) . The total extracts from the insect cells incubated with [3H]myristate were also analysed (Fig. 3, lanes 4 to 6) . It is apparent that the FMDV lAB product is a significant myristatecontaining species in the Ac611 MRl-infected cells (lane 5). The pattern of myristate incorporation is quite different between the uninfected and infected insect cells (lane 4; compare lanes 5 and 6). Three major products of about 70K, 22K and 15K are strongly labelled in the AcNPV-infected cells. The largest product may correspond to the major envelope glycoprotein, gp67, which has a putative acylation site near the carboxy terminus (Whitford et al., 1989) , however this would require intracellular conversion of the myristate to palmitate (Towler et al., 1988) . Previous studies on poliovirus (Marc et al., 1989; Krausslich et al., 1990) have shown that the substitution of the terminal glycine residue not only abolishes the infectivity of the mutant RNA transcripts but also inhibits the in vitro processing of the P1 precursor by 3CD. In FMDV the processing of the P1-2A precursor is achieved by 3C alone and in contrast to these results, with poliovirus the loss of myristoylation does not inhibit the processing of the modified capsid precursor (ALP1-2A from cassette CA103) by the 3C protease since the products 1C, 1D and forms of AL1AB are observed (see Fig. 2 and . This suggests that the presence of the myristate moiety has a function distinct from that of processing of the capsid precursor. Recently Marc et al. (1990) have shown that RNA transcripts of myristoylation-deficient mutants of poliovirus replicate and produce processed products within cells but these products assemble inefficiently. Thus within cells no role for myristoylation in permitting capsid protein processing has been established. 1 2 3 4 5 6 produced by the entero-and rhinoviruses where the same modification has to occur. W e have previously shown that the L protease is not tolerated within vaccinia virus and furthermore baculovirus ( A c N P V ) r e c o m b i n a n t s expressing this protein can be isolated only when the expression level is low (Roosien et al.,1990) . It seems likely that is due to the ability of the L protein to inhibit the expression of other genes p r o b a b l y by initiating the cleavage of the p220 capbinding complex protein (Devaney et al., 1988) . The C A K cassette lacks the L protease but still produces correctly processed and myristoylated F M D V capsid proteins and hence r e c o m b i n a n t viruses which express cassettes of this type should be useful for m a k i n g empty capsid particles.
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The precise removal of the L protein coding sequence from the MR1 cassette to produce the C A K cassette results in the production of a P1-2A precursor which contains a m e t h i o n i n e residue at its N terminus rather than the glycine residue left by the cleavage of the L protease. A normal p a t t e r n of myristoylation of l A B is observed from this product. Thus the P1-2A product from C A K behaves similarly to the capsid precursor
